TABLE 1.
Characteristics of the patients
| Characteristics | Patients (n=27) | Reference range |
|---|---|---|
| Age (years) | 58 (20‐90) | |
| Gender | ||
| Female | 55,6% | |
| Male | 44,4% | |
| Cardiovascular risk factors | ||
| Hypertension | 37% | |
| Dyslipidemia | 33% | |
| Diabetes | 11% | |
| Smoker | 14,8% | |
| Obesidad (BMI > 30 Kg/m2) | 18,5% | |
| Medical history | ||
| Autoimmune disease | 11.1% (3/27) | |
| Cancer | 7% (2/27) | |
| Laboratory findings | ||
| Hemoglobin | 13,6 (9,2‐16,2) | g/dL [13.0‐16.8] |
| Platelets | 222.000 ( 108.000‐599.000) | ×1000/µL [140‐450] |
| Lymphocytes | 1100 (100‐3100) | ×1000/µL [1.2‐4.0] |
| LDH | 329 (190‐811) | U/L [135‐225] |
| CRP | 7,32 (0,04‐36,6) | mg/dL [0.10‐0.50] |
| Ferritin | 1070 (137‐7459) | ng/mL [30‐400] |
| Fibrinogen | 648 (373‐1412) | mg/dL [200‐560] |
| IL‐6 | 252 (0‐782) | pg/mL [<40] |
| D‐dimer | 2367 (223‐8138) | ng/mL [<500] |
| Prothrombin activity | 83 (60‐115) | % [75‐140] |
| Prothrombin time | 12,8 (10,7‐16,5) | s [9.7‐13.9] |
| aPTT | TTPa: 32 (21‐48) | s [26‐39] |
| Lupus anticoagulant | 22,2% (6/27) | |
| Anticardiolipin antibodies | 0% (0/27) | |
| Anti‐B2 glycoprotein I antibodies | 3,7% (1/27) | |
| ICU | ||
| Admission | 22,2% (6/27) | |
| Median stay (days) | 25 (6‐30) | |
| Thrombotic event | ||
| Arterial | Lower extremities arterial ischemia 7,4% (2/27) | |
| Venous | Deep vein thrombosis 22,2% (6/27) | |
| Pulmonary embolism 37% (10/27) | ||
| Stroke 7,4% (2/27) | ||
| Death | 11,1% (3/27) | |